Chronic Kidney Disease Trial, Recruiting NCT06458322 Sponsor: Ciusss de L'Est de l'Île de Montréal Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT06458322
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults who are being seen at a clinic for advanced chronic kidney disease
  • People whose kidneys are functioning at a very low level (a measure called eGFR at or below 12 mL/min/1.73m²) (confirm with trial site)
  • People who can communicate in English or French

Who may not be able to join:

  • People whose care team has directed their treatment toward comfort-focused or non-dialysis care rather than kidney replacement therapy
  • People who have a kidney transplant planned within the next 6 months
  • People who are unable to give informed consent due to a severe cognitive or psychiatric condition
  • People who have previously been on dialysis for more than 3 months
  • People whose life expectancy is estimated to be less than 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Annie-Claire Nadeau-Fredette, MD, Ciusss de L'Est de l'Île de Montréal

Phone: 514-252-3400

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ciusss de L'Est de l'Île de Montréal
Registry
ClinicalTrials.gov
Start date
1 July 2022
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Change in Kidney Disease Quality of Life - 36

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov